On May 24, 2010, Pharmaceutical Product Development, Inc. (NASDAQ: PPDI) announced the distribution date of the spin-off of Furiex Pharmaceuticals. Shares of Furiex Pharmaceuticals will be distributed via a tax-free distribution on June 14, 2010, to shareholders of record on June 1, 2010. Furiex Pharmaceuticals shares are expected to begin trading ‘regular way’ on the Nasdaq Global Market on June 15, 2010, under the ticker symbol ‘FURX.’ Shareholders of PPDI will receive one share of FURX for every twelve shares held.
We are maintaining our fair value estimate for Furiex Pharmaceuticals of $5 per share based on the finalized exchange ratio of 1:12, which we believe is an adequate margin of safety for those investors with a risk tolerance suitable for this speculative investment. Furiex will be capitalized with $100 million in cash, equivalent to just over $10 per share, which should fund research and development for close to two years. Further, the company has the potential to realize growth in royalty and milestone payments in the near-term, which could create shareholder value going forward. However, until there is greater visibility into the magnitude of the company’s sustainable revenues (i.e. royalty payments), we are recommending a significant degree of caution as evidenced by a fair value estimate that reflects a steep discount to cash on hand.
For those investors with a short-term trading focus, Furiex may present a compelling opportunity within the first few days of regular-way trading. Given the speculative nature of the spin-off and the discrepancies in market capitalization between spin-off and the parent company, shares of Furiex may be sold indiscriminately upon distribution. This may allow investors to purchase shares at a significant discount to our fair value estimate and capture the potential rebound in share price as Furiex shares begin to reflect the value of their $100 million net cash position.
Due to its expected market capitalization, we will not be providing coverage of Furiex Pharmaceuticals beyond the distribution date.